Benzinga - by Lisa Levin, Benzinga Editor.
Gainers
- Orchard Therapeutics plc (NASDAQ: ORTX) shares rose 95.5% to $15.80 in pre-market trading after the company inked a deal with Kyowa Kirin Co., Ltd. to be acquired for $16.00 per ADS in cash plus an additional contingent value right of $1.00 per ADS, representing a total value of about $477.6 million.
- Meiwu Technology Company Limited (NASDAQ: WNW) shares gained 62.3% to $0.1573 in pre-market trading after falling 4% on Wednesday.
- Molekule Group, Inc. (NASDAQ: MKUL) shares rose 38.7% to $0.1595 in pre-market trading. Molekule Group shares fell 44% on Wednesday after the company and its subsidiary filed for Chapter 11 bankruptcy.
- Femasys Inc. (NASDAQ: FEMY) rose 27.5% to $2.92 in pre-market trading after falling 8% on Wednesday.
- NKGen Biotech, Inc. (NASDAQ: NKGN) rose 20.9% to $5.96 in pre-market trading. NKGen Biotech recently announced that it has closed its previously announced business combination with Graf Acquisition Corp. IV.
- Grom Social Enterprises, Inc. (NASDAQ: GROM) shares climbed 18.8% to $2.08 in pre-market trading after gaining around 13% on Wednesday.
- Better Choice Company Inc. (NYSE: BTTR) shares jumped 15.5% to $0.1848 in pre-market trading after gaining 12% on Wednesday.
- Momentus Inc. (NASDAQ: MNTS) gained 14.6% to $1.26 in pre-market trading. Momentus announced closing of $4.0 million registered direct offering priced at-the-market under Nasdaq rules.
- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) shares rose 12.3% to $3.37 in pre-market trading. China SXT Pharmaceuticals reported a 1-for-25 reverse stock split.
- Tenaya Therapeutics, Inc. (NASDAQ: TNYA) shares surged 10.7% to $2.38 in pre-market trading after falling over 8% on Wednesday.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- Cambium Networks Corporation (NASDAQ: CMBM) fell 27.8% to $5.72 in pre-market trading after the company reported preliminary revenue for the third quarter. Cambium Networks said it sees revenues of $40 million to $45 million, versus prior forecast of $62 million to $70 million. The company also suspended its guidance for the full year 2023.
- SIGNA Sports United N.V. (NYSE: SSU) fell 23.2% to $0.1090 in pre-market trading.
- MaxCyte, Inc. (NASDAQ: MXCT) shares fell 21.4% to $2.57 in pre-market trading. MaxCyte said it sees third-quarter total revenue of $7.8 to 8.0 million, representing a decrease of 25% -27% versus the year-ago quarter. The company now expects total revenue of approximately $34 million to $36 million for the year.
- Neoleukin Therapeutics, Inc. (NASDAQ: NLTX) fell 13.8% to $3.45 in pre-market trading. Neoleukin Therapeutics recently reported a 1-for-5 reverse stock split.
- Safety Shot, Inc. (NASDAQ: SHOT) fell 12% to $1.10 in pre-market trading after declining more than 10% on Wednesday.
- Benson Hill, Inc. (NYSE: BHIL) shares fell 10.5% to $0.2913 in pre-market trading after gaining 3% on Wednesday.
- Inspirato Incorporated (NASDAQ: ISPO) fell 10.3% to $0.56 in pre-market trading. Inspirato said it has closed its $25 million senior secured convertible note issued by Inspirato to Capital One Ventures.
- Accolade Inc (NASDAQ: ACCD) shares fell 9.2% to $8.85 in pre-market trading after the company reported second-quarter results. Accolade said it sees FY24 revenue of $410 million to $414 million.
- SeaStar Medical Holding Corporation (NASDAQ: SSU) fell 8.8% to $0.5392 in pre-market trading. SeaStar Medical recently issued a regulatory update regarding selective cytopheretic device use in pediatric acute kidney injury under a humanitarian device exemption.
- Resources Connection, Inc. (NASDAQ: RGP) fell 8.5% to $13.25 in pre-market after the company reported first-quarter financial results.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.